TB research requires strong protections, innovation, and increased funding in response to COVID-19.

Nyang'wa, B T; LaHood, A N; Mitnick, C D; Guglielmetti, L

Nyang'wa, B T; LaHood, A N; Mitnick, C D; Guglielmetti, L.

Afiliación

Nyang'wa BT; Manson Unit, Médecins Sans Frontières, London, UK.
LaHood AN; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.
Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Guglielmetti L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, 02115, USA. carole_mitnick@hms.harvard.edu.

Trials ; 22(1): 371, 2021 05 29.

Article en En | MEDLINE | ID: mdl-34051826

Asunto(s)

Investigación Biomédica; COVID-19; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Investigación Biomédica / COVID-19 Límite: Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google